In PD pathology, downregulated TRPV1 inhibits AMPK signaling and induces the expression of IL‐1β, inducible nitric oxide synthase (iNOS), and cyclooxygenase‐2 (COX‐2) [37]. This evidence concerns the gene TRPV1 and Parkinson disease.